Eye doctors fighting Genentech decision

The California Academy of Eye Physicians and Surgeons has issued a call for South San Francisco’s Genentech Inc. (DNA) to reverse its decision to halt sales of its drug Avastin to compounding pharmacies effective November 30, 2007.

The group is asking the California Medical Association and possibly the American Medical Association to take a stand on the issue as well.

Opthalmologists have been using Avastin, a drug currently only approved for cancer, to treat age-related macular degeneration, a common eye disease. Because only a small portion of a standard dose is needed for eye treatment, eye doctors have generally purchased the drug from compounding pharmacies, which repackage it in smaller doses.

Genentech, however, also sells a similar but much more expensive drug, Lucentis, which according to information provided by the physicians sells for approximately $2,000 a dose versus approximately $40 a dose for Avastin.

businessBusiness & Real Estate

If you find our journalism valuable and relevant, please consider joining our Examiner membership program.
Find out more at www.sfexaminer.com/join/

Just Posted

Cyclists have flocked to Market Street since private vehicles were largely banned from a long stretch of it in January. (Amanda Peterson/Special to the S.F. Examiner)
Plans for sidewalk-level bikeway on Market Street dropped due to costs, increased cyclist volume

Advocates say revisions to Better Market Street fail to meet safety goals of project

Anti-eviction demonstrators rally outside San Francisco Superior Court. (Kevin N. Hume/S.F. Examiner)
Report: Unpaid rent due to COVID-19 could be up to $32.7M per month

A new city report that attempts to quantify how much rent has… Continue reading

Music venues around The City have largely been unable to reopen due to ongoing pandemic health orders. (Kevin N. Hume/S.F. Examiner)
SF to cut $2.5M in fees to help 300 nightlife venues

San Francisco will cut $2.5 million in fees for hundreds of entertainment… Continue reading

Supreme Court nominee Judge Amy Coney Barrett departs the U.S. Capitol on October 21, 2020 in Washington, DC. President Donald Trump nominated Barrett to replace Justice Ruth Bader Ginsburg after Ginsburg’s death. (Photo by Stefani Reynolds/Getty Images)
GOP senators confirm Amy Coney Barrett to Supreme Court in partisan vote

By Jennifer Haberkorn Los Angeles Times The Senate on Monday confirmed Judge… Continue reading

Curator Tim Burgard looks over a section of the galleries comprising “The de Young Open,” a huge, varied collection of work by Bay Area artists. (Photo courtesy Gary Sexton/Fine Arts Museums of San Francisco)
Bay Area artists jam-pack vivid ‘de Young Open’

Huge exhibition — with works for sale — showcases diversity, supports community

Most Read